Building on the resounding success of the last 6 Cell & Gene Therapy Forums, the 2011 event will once again provide a highly valuable meeting place for senior level figures driving the transition of these technologies into safe-commercially-viable products.

The 3 day conference program will feature a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and cell and gene therapy developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive.

In 2011, the Cell & Gene Therapy Forum will once again run concurrently with Phacilitate’s annual North American Vaccine Forum. Participants will be able to select the conference agenda of greatest current value to themselves and their organization, with all networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area.

"I found many of the presentations to be informative and insightful. The networking sessions were outstanding and a big plus"

Robert Speziale, Vice President, Business Development, Invetech

A total of 500+ senior level attendees participated in 2010. For more information on how your company can raise it’s profile with both sets of attendees all under one roof and in just three days at the '11 event, please click here.